Loading...
XASX
PCK
Market cap53mUSD
Nov 27, Last price  
0.04AUD
Name

PainChek Ltd

Chart & Performance

D1W1MN
XASX:PCK chart
P/E
P/S
2.89
EPS
Div Yield, %
Shrs. gr., 5y
11.64%
Rev. gr., 5y
65.46%
Revenues
3m
+37.06%
00003,89231,11650,647215,464248,194214,798978,5671,949,5132,671,938
Net income
-8m
L+9.68%
-405,639-1,099,388-792,267-1,703,733-5,047,449-8,473,802-4,810,532-3,262,418-12,392,659-6,063,647-5,720,534-7,574,728-8,307,957
CFO
-7m
L+12.73%
0000-2,443,805-1,577,879-2,913,032-3,074,896-1,886,689-4,121,050-6,997,500-6,322,717-7,127,557

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PainChek Limited develops and commercializes mobile medical device applications that provides pain assessment for individuals. The company offers PainChek, which uses camera in smartphones and tablets to capture video that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
IPO date
May 01, 2012
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT